Hara Capital’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.23K Hold
20
– – ﹤0.01% 269
2026
Q2
$3.79K Hold
20
– – ﹤0.01% 271
2026
Q1
$3.94K Hold
20
– – ﹤0.01% 283
2025
Q4
$3.68K Hold
20
– – ﹤0.01% 271
2025
Q3
$3.07K Hold
20
– – ﹤0.01% 271
2025
Q2
$2.8K Hold
20
– – ﹤0.01% 301
2025
Q1
$2.94K Hold
20
– – ﹤0.01% 265
2024
Q4
$2.62K Hold
20
– – ﹤0.01% 274
2024
Q3
$3.12K Buy
+20
New +$3.23K ﹤0.01% 279

Other funds holding AZN

Hara Capital's AZN Position: Q3 2026 in Review

Hara Capital held its AstraZeneca (AZN) position steady in Q3 2026 at 20 shares worth $3.23K. The position accounts for ﹤0.01% of the portfolio, ranked #269.

Hara Capital first reported a position in AZN in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.94K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Hara Capital held 20 shares of AstraZeneca worth $3.23K as of Q3 2026.
  • Hara Capital left its AstraZeneca share count unchanged in Q3 2026.
  • AstraZeneca made up ﹤0.01% of Hara Capital's portfolio in Q3 2026, its #269 holding.
  • Hara Capital first reported a position in AstraZeneca in Q3 2024 and has held it in 9 quarters since.
  • Hara Capital's AstraZeneca position peaked at $3.94K in Q1 2026.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Hara Capital's 13F filing for Q3 2026, filed 30 Oct 2026.